Bioventix PLC (AIM:BVXP)
London · Delayed Price · Currency is GBP · Price in GBX 1,425.00
+25.00 (1.79%)
At close: Mar 25, 2026
Bioventix Market Cap
Bioventix has a market cap or net worth of 73.15 million as of March 25, 2026. Its market cap has decreased by -50.83% in one year.
Market Cap
73.15M
Enterprise Value
68.07M
Revenue
13.12M
Ranking
n/a
PE Ratio
9.77
Stock Price
1,425.00
Market Cap Chart
Since April 8, 2010, Bioventix's market cap has increased from 9.85M to 73.15M, an increase of 642.81%. That is a compound annual growth rate of 13.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 74.45M | -25.20% |
| Dec 31, 2025 | 99.53M | -39.94% |
| Dec 31, 2024 | 165.72M | -26.16% |
| Dec 29, 2023 | 224.45M | 7.98% |
| Dec 30, 2022 | 207.85M | 17.35% |
| Dec 31, 2021 | 177.12M | -22.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scancell Holdings | 116.75M |
| 4basebio | 73.98M |
| Hemogenyx Pharmaceuticals | 61.43M |
| Ondine Biomedical | 55.85M |
| Faron Pharmaceuticals Oy | 49.79M |
| hVIVO | 44.90M |
| Poolbeg Pharma | 29.09M |
| ImmuPharma | 23.88M |